China's existing pharmaceutical enterprises more than 8,700, through GMP pharmaceutical production enterprises more than 6000, the State Food and Drug Administration registered a total of more than 3000 raw materials production enterprises, pharmaceutical intermediate production enterprises also accounted for a larger proportion.
From 2008 to the present, China's API exports have grown at a cagrtime rate of more than 20%, and in 2009 exports reached 17.58 billion U.S. dollars, an increase of 29.59 percent year-on-year. Exports to the API industry is becoming more and more obvious and important, directly promoting the improvement of the industry's profit level, in January-November 2012, THE profit of API profits of 15.59 billion yuan, an increase of up to 49.5%.